Calendar Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen 11:20:00 2024-07-18 am EDT 5-day change 1st Jan Change
1,852 DKK +1.23% Intraday chart for Genmab A/S +2.98% -14.08%

Chart calendar Genmab A/S

5860dcb198e3d8223c.Me2QtWrbaobXtSW6HgpY3qU8bBzaw1pKeh39ceCLI4c.f9r7wQaXU_Hm8UDfLCcHve9fFEuSqC8LT3ecOazAZPYGmMDzJo4y7YSYYA~57ce80de300723d1e84a8c6dfb102ee6

Upcoming events on Genmab A/S

2024-08-01 11:00 am Q2 2024 Earnings Release
2024-11-06 11:00 am Q3 2024 Earnings Release
2025-02-18 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)
2025-08-05 Q2 2025 Earnings Release (Projected)
2025-11-04 Q3 2025 Earnings Release (Projected)

Past events on Genmab A/S

2024-06-15 10:30 am European Hematology Association Meeting - Abstract Number :S234
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1244
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1133
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1140
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1121
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1114
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1161
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1152
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1151
2024-06-14 12:00 pm European Hematology Association Meeting - Abstract Number :P1146
2024-06-14 08:45 am European Hematology Association Meeting - Abstract Number :S239
2024-06-14 08:45 am European Hematology Association Meeting - Abstract Number :S163
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :P2059
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :P2081
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :PB2955
2024-06-14 03:00 am European Hematology Association Meeting - Abstract Number :P2060
2024-06-10 09:20 am Goldman Sachs Global Healthcare Conference
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:TPS7084
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7039
2024-06-03 10:00 am American Society of Clinical Oncology Meeting - Abstract No:7037

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million DKK
Released
Forecast
Spread
5 366
5 159
4.02%
10 111
9 843
2.72%
8 482
8 376
1.26%
14 595
14 068
3.75%
16 474
16 380
0.58%

19 863

EBITDA
Million DKK
Released
Forecast
Spread
2 777
2 460
12.89%
6 572
6 099
7.75%
3 266
3 111
4.98%
6 719
6 371
5.46%
5 616
5 721
-1.83%

6 271

EBIT
Million DKK
Released
Forecast
Spread
2 638
2 317
13.83%
6 313
5 967
5.79%
3 018
2 960
1.96%
6 357
6 008
5.81%
5 321
5 398
-1.42%

5 972

Earnings before Tax (EBT)
Million DKK
Released
Forecast
Spread
2 859
2 645
8.11%
5 904
5 723
3.17%
3 983
3 731
6.77%
7 035
8 905
-21%
5 637
6 236
-9.6%

6 958

Net income
Million DKK
Released
Forecast
Spread
2 166
2 085
3.89%
4 758
4 706
1.1%
3 008
2 847
5.64%
5 522
6 793
-18.71%
4 352
4 989
-12.77%

5 324

EPS
DKK
Released
Forecast
Spread
34,0
32,8
3.61%
72,2
69,4
4.06%
45,5
43,8
3.94%
83,7
104
-19.22%
66,0
76,2
-13.35%

81,8

Announcement Date19/02/2023/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1
Net sales
Million DKK
Released
Forecast
Spread
6 343
6 164
2.9%
3 553
3 224
10.2%
2 619
2 538
3.19%
2 119
2 074
2.15%
3 162
2 833
11.6%
5 281
5 136
2.82%
4 087
3 634
12.46%
5 227
4 727
10.57%
2 854
2 809
1.62%
4 198
4 070
3.13%
7 052
6 896
2.26%
4 744
4 474
6.03%
4 678
4 610
1.48%
4 143
3 978
4.15%

4 951


9 039


5 308


5 602


4 858

EBITDA
Million DKK
Released
Forecast
Spread
4 583
4 480
2.3%
1 345
980
37.24%
1 016
776
30.87%
529
358
47.73%
1 263
1 312
-3.74%
1 792
1 951
-8.15%
1 953
1 583
23.36%
2 974
2 708
9.84%
458
583
-21.48%
1 520
1 670
-8.96%
1 978
2 145
-7.79%
1 739
1 646
5.65%
1 899
1 804
5.28%
823
882
-6.66%

1 571


2 412


1 730


1 917


970

EBIT
Million DKK
Released
Forecast
Spread
4 568
4 389
4.08%
1 319
864
52.66%
809
772
4.76%
514
442
16.3%
1 247
1 156
7.87%
1 761
1 814
-2.92%
1 931
1 541
25.34%
2 665
2 314
15.17%
437
527
-17.08%
1 497
1 573
-4.85%
1 934
1 977
-2.18%
1 717
1 702
0.87%
1 670
1 772
-5.73%
801
788
1.64%

1 591


2 229


1 699


1 866


927

Earnings before Tax (EBT)
Million DKK
Released
Forecast
Spread
4 682
4 682
0%
1 846
1 759
4.95%
966
772
25.06%
612
499
22.59%
2 489
1 183
110.39%
3 101
1 932
60.51%
3 272
1 584
106.63%
662
2 199
-69.9%
286
402
-28.85%
1 723
1 602
7.57%
2 009
1 927
4.26%
2 702
1 774
52.33%
926
1 888
-50.95%
1 716
921
86.25%

1 847


3 374


1 891


1 686


696

Net income
Million DKK
Released
Forecast
Spread
3 647
4 573
-20.25%
1 402
1 372
2.19%
716
603
18.69%
465
357
30.19%
1 891
913
107.1%
2 356
1 469
60.38%
2 582
1 187
117.46%
584
1 556
-62.47%
226
397
-43.08%
1 357
1 204
12.72%
1 583
1 503
5.32%
2 129
1 382
54.01%
640
1 439
-55.52%
1 325
779
70.01%

1 426


2 598


1 474


1 270


549

EPS
DKK
Released
Forecast
Spread
55,5
70,2
-20.91%
21,3
20,9
1.67%
10,8
9,25
16.99%
7,05
5,39
30.88%
28,7
13,8
106.99%
35,7
22,1
61.58%
39,2
18,3
113.88%
8,82
23,2
-61.91%
3,43
5,07
-32.28%
20,6
19,3
7.03%
24,0
22,7
5.86%
32,3
21,2
52.42%
9,67
23,0
-57.93%
20,2
10,6
90.39%

22,8


39,5


21,7


20,7


18,1

Announcement Date12/08/2011/08/2116/02/2211/05/2210/08/2210/08/2209/11/2222/02/2310/05/2303/08/2303/08/2307/11/2314/02/2402/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise